Company / EPS (Basic)
Opus Genetics, Inc. EPS (Basic) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$2.15
FY2025
5-year range
-$5.28 / $0.90
FY2021-FY2025
Trend
-367.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) changed -367% YoY in FY2025, a notable deviation from the 4-year average annual change of -92%.
Based on SEC 10-K filings.
-2.15 in FY2025.
Declined from $0.90 to $-2.15 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) decreased 367.4% year-over-year.
- Peak eps (basic) was recorded in FY2023.
- Lowest eps (basic) in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.15 | -367.4% |
| FY2024 | -$0.46 | -151.1% |
| FY2023 | $0.90 | +123.6% |
| FY2022 | -$3.82 | +27.7% |
| FY2021 | -$5.28 | - |
| FY2013 | - | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026